New Universal Flu Vaccine Offers Broad Protection Against Influenza A Virus Infections
A new universal flu vaccine constructed with key parts of the influenza virus offers broad cross protection against different strains ...
Tag: Vaccines
Adverse Events After Simultaneous COVID-19 mRNA Booster, Flu Vaccination
Are systemic reactions more common after simultaneous administration of COVID-19 mRNA booster and seasonal influenza vaccines than after COVID-19 mRNA ...
US Starts Clinical Trial for mRNA Nipah Virus Vaccine
The experimental Nipah virus vaccine (mRNA-1215) is manufactured by Moderna, Inc. and was developed in collaboration with NIAID’s Vaccine Research ...
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
New guidance on offering the Imvanex vaccine to men considered to be at higher risk of exposure. A strategy published today by ...
Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs
Internal Manufacturing Capabilities Expected to Support U.S. Pandemic Preparedness Tonix Pharmaceuticals will hold a ribbon-cutting ceremony at the company’s new ...
Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit
As Aotearoa New Zealand heads into the colder winter months, the pressures on our health system and staff are growing ...
Politics and Pandemic Fatigue Doom California’s Covid Vaccine Mandates
In January, progressive California Democrats vowed to adopt the toughest Covid vaccine requirements in the country. Their proposals would have ...
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Bavarian Nordic's smallpox vaccine is approved for use against monkeypox by the U.S. Food and Drug Administration and Health Canada. ...
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Novavax hitched its wagon to the global coronavirus pandemic. Before most Americans truly grasped the scope of the danger, the ...
NIH Awards $3M Grant to Albany Med for Plague Vaccine Development
Albany Medical College scientists have been awarded a $3 million, five-year federal grant to develop a vaccine that could protect ...
Northwestern University Researchers Develop Nanoparticle Vaccine Platform
Nanoparticle-based COVID-19 vaccine could target future infectious diseases Just one dose of a new nanoparticle-based COVID-19 vaccine was enough to ...
New NIH Study Will Follow Patients That Had Allergic Reaction to mRNA COVID-19 Vaccines
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) are conducting a clinical trial designed to help understand ...
Newborn Rotavirus Vaccine Set to Save Lives
The award-winning team behind an affordable and effective gastro vaccine is ensuring it will save as many newborn lives as ...
Appili Awarded $10M in New Biodefense Funding for Tularemia Vaccine Candidate
DoD funding aims to advance F. tularensis biodefense vaccine candidate to IND submission Appili Therapeutics Inc. announced this week that ...
Zika Virus Vaccine Shows Promising Results in Preclinical Studies
A Zika virus vaccine candidate is effective at preventing the Zika virus passing from mother to fetus in preclinical animal ...
Israel is Rolling Out Fourth Doses of COVID Vaccines to Everyone. Should Others Follow?
Earlier this year, Israel began offering a fourth dose of the Pfizer mRNA vaccine to people who are immunocompromised, older ...
Some Cancers are Preventable with a Vaccine – a Virologist Explains
One-fifth. Nearly 20% of cancers worldwide are caused by a virus. These viruses don’t cause cancer until long after they ...
Three Doses of mRNA COVID-19 Vaccines Effective Against Hospitalizations for Omicron and Delta
A nationwide study from the Centers for Disease Control and Prevention (CDC) has found that mRNA booster shots (either Pfizer ...
How Effective Are Vaccines Against Omicron?
The pandemic has brought many tricky terms and ideas from epidemiology into everyone’s lives. Two particularly complicated concepts are vaccine ...
Preclinical Studies Support Army’s Pan-Coronavirus Vaccine Development Strategy
Pre-clinical studies published today in Science Translational Medicine indicate that the SpFN vaccine protects non-human primates from disease caused by ...
